Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,606Revenue $M1,417Net Margin (%)-7.0Z-Score4.6
Enterprise Value $M16,981EPS $-2.4Operating Margin %0.2F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-0.8Higher ROA y-yN
Price/Book17.010-y EBITDA Growth Rate %0Quick Ratio3.1Cash flow > EarningsY
Price/Sales11.95-y EBITDA Growth Rate %0Current Ratio4.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-227.8ROA % (ttm)-3.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-10.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M218ROI % (ttm)20.8Gross Margin Increase y-yN

Gurus Latest Trades with VRTX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 78.4870%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 78.4870%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 78.4847%Add 40%700,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 78.4847%Sold Out0
VRTXJohn Burbank 2012-09-30 Reduce-0.09%$48.38 - $59.07
($53.5)
$ 78.4847%Reduce -25%150,000
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 78.4847%Sold Out0
VRTXDaniel Loeb 2012-06-30 Buy 0.85%$35.75 - $65.62
($50.92)
$ 78.4854%New holding, 500000 sh.500,000
VRTXJohn Burbank 2012-06-30 Buy 0.38%$35.75 - $65.62
($50.92)
$ 78.4854%New holding, 200000 sh.200,000
VRTXJoel Greenblatt 2012-06-30 Buy 0.08%$35.75 - $65.62
($50.92)
$ 78.4854%New holding, 20025 sh.20,025
VRTXJohn Hussman 2012-06-30 Sold Out -0.93%$35.75 - $65.62
($50.92)
$ 78.4854%Sold Out0
VRTXGeorge Soros 2012-06-30 Reduce-0.05%$35.75 - $65.62
($50.92)
$ 78.4854%Reduce -44%112,000
VRTXJean-Marie Eveillard 2012-06-30 Sold Out -0.02%$35.75 - $65.62
($50.92)
$ 78.4854%Sold Out0
VRTXGeorge Soros 2012-03-31 Buy 0.12%$32.2 - $42.94
($35.95)
$ 78.48118%New holding, 200000 sh.200,000
VRTXJean-Marie Eveillard 2012-03-31 Buy 0.02%$32.2 - $42.94
($35.95)
$ 78.48118%New holding, 110000 sh.110,000
VRTXJohn Hussman 2012-03-31 Reduce-0.34%$32.2 - $42.94
($35.95)
$ 78.48118%Reduce -35%1,170,000
VRTXRay Dalio 2012-03-31 Sold Out -0.24%$32.2 - $42.94
($35.95)
$ 78.48118%Sold Out0
VRTXJohn Hussman 2011-12-31 Buy 0.96%$26.6 - $45.12
($35.09)
$ 78.48124%New holding, 1800000 sh.1,800,000
VRTXRay Dalio 2011-12-31 Add0.22%$26.6 - $45.12
($35.09)
$ 78.48124%Add 1038.59%437,458
VRTXVanguard Health Care Fund 2011-12-31 Add0.04%$26.6 - $45.12
($35.09)
$ 78.48124%Add 9.59%2,743,700
VRTXGeorge Soros 2011-06-30 Sold Out $45.01 - $58.01
($51.47)
$ 78.4852%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX Vanguard Health Care Fund 2013-03-312,489,8001.140.54+10.97%
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SMITH IAN FEVP & CFO 2013-05-15Sell609$79.67-1.56view
Silva Paul MSVP & Corp Controller 2013-05-15Sell609$79.66-1.54view
Stamoulis ChristianaSVP, Corp Strategy & Bus Devlp 2013-05-15Sell602$79.65-1.53view
BOGER JOSHUA SDirector 2013-05-15Sell1,400$79.36-1.17view
SACHS BRUCE IDirector 2013-05-14Sell60,000$81.15-3.35view
SACHS BRUCE IDirector 2013-05-06Sell8,300$77.221.57view
Silva Paul MSVP & Corp Controller 2013-05-06Sell230$76.123.03view
Silva Paul MSVP & Corp Controller 2013-05-03Sell2,062$76.822.1view
ULLIAN ELAINEDirector 2013-05-03Sell40,000$77.990.56view
Stamoulis ChristianaSVP, Corp Strategy & Bus Devlp 2013-04-30Sell83,000$79.5-1.35view

Press Releases about VRTX:

Quarterly/Annual Reports about VRTX:

News about VRTX:

Articles On GuruFocus.com
Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
Idenix: Strong Pipeline Will Reward Investors Apr 24 2012 
Columbia Management Fourth Quarter Letter with Comments on SWK, AGCO, CE, MCP, VRTX, DOLE, F, HAS, A Apr 10 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
4 Pharmaceuticals with Long and Short Opportunities Feb 28 2012 
Hussman Fund Q4 Portfolio Overview Feb 02 2012 
John Hussman’s Biggest Fourth-Quarter Buys Jan 31 2012 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK